NCT05782374View on ClinicalTrials.gov

Real World Data on Ibrutinib Use in PCNSL Rel/Ref

Active, not recruitingOBSERVATIONAL

Enrollment

36

Participants

Timeline

Start Date

August 10, 2022

Primary Completion Date

January 10, 2023

Study Completion Date

August 10, 2026

Conditions

PCNSL

Interventions

DRUG

Ibrutinib

ibrutinib alone or in combination with R-CHOP or R-CHOP like

Trial Locations (1)

20132

Ospedale San Raffaele, Milan

All Listed Sponsors

lead

IRCCS San Raffaele

OTHER